See the DrugPatentWatch profile for Nplate
What is Nplate (romiplostim) used for?
Nplate is a prescription medicine (romiplostim) used to treat chronic immune (idiopathic) thrombocytopenic purpura (ITP) in adults who have had an inadequate response to other ITP treatments. It works by helping increase platelet counts, which lowers the risk of bleeding when platelets are low. [1]
How does Nplate work?
Nplate is a thrombopoietin receptor agonist. It stimulates the body’s platelet-producing pathways, raising platelet production and helping patients maintain safer platelet levels. [1]
How is Nplate given (and how often)?
Nplate is given by injection. The dosing schedule depends on blood test results (platelet counts), and clinicians adjust the dose to keep platelets within a target range to reduce bleeding risk while avoiding excessively high platelet counts. [1]
What are common side effects people ask about?
Side effects can include headache, dizziness, and symptoms related to increased or fluctuating platelet counts. Because Nplate changes platelet levels, your clinician monitors blood counts closely to reduce complications. [1]
What risks are most important with Nplate?
The key safety concern is that platelet counts can rise too much if dosing is not adjusted, which can increase the risk of clotting or other complications. That is why platelet monitoring and dose adjustments are central to treatment. [1]
Who should not take Nplate (or who needs extra caution)?
People with conditions that increase clotting risk may need extra caution. Your prescriber also considers your other medications and overall risk profile, since Nplate dosing is managed based on platelet trends and targets. [1]
How long do patients stay on Nplate?
Treatment duration varies by response. Some patients need ongoing therapy to keep platelet counts in range, while others can reduce or stop therapy under clinician supervision based on platelet response and ITP course. [1]
What do patients typically monitor during treatment?
Patients typically have periodic complete blood count (CBC) tests to measure platelet counts. Doses are adjusted based on those results to maintain a balance between reducing bleeding risk and avoiding overly high platelet levels. [1]
---
Sources
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125205